NCT03212495View on ClinicalTrials.gov

Intra-articular Dexmedetomidine Versus Neostigmine After Knee Arthroscopy (a Comparative Study)

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

November 1, 2017

Study Completion Date

December 1, 2017

Conditions
Knee Injuries
Interventions
DRUG

dexamedetomidine

intraarticular injection of 1µg/kg dexametomidine +18ml 0.25%bubivacaine in a total volume of 20 ml.

DRUG

neostigmine

intraarticular injection of 0.5mg/dose neostigmine +18ml 0.25%bubivacaine in a total volume of 20 ml.

Trial Locations (1)

Unknown

Assiut governorate, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03212495 - Intra-articular Dexmedetomidine Versus Neostigmine After Knee Arthroscopy (a Comparative Study) | Biotech Hunter | Biotech Hunter